A novel nanobody-based immunosensor, designed to function stably in undiluted biological fluids and harsh conditions, has been developed. Their innovative design leverages BRET -- bioluminescence ...

A clinical trial led by Kirby Institute at UNSW Sydney has found that point-of-care testing for hepatitis B DNA is as effective as traditional laboratory testing, paving the way for faster diagnosis ...

Every second counts in the Intensive Care Unit (ICU), with changes in patient status potentially occurring quickly and with no prior warning. Around-the-clock blood testing capabilities are essential ...

In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

Speed and precision are two of the most vital considerations when it comes to patient care in the high-stakes environment of the Emergency Department (ED). Thus, swift decision-making and accurate ...

Credit: Cepheid. The Xpert HCV test delivers results in about an hour. The Food and Drug Administration (FDA) has granted marketing authorization to Xpert ® HCV, a point-of-care hepatitis C virus (HCV ...

Point of care devices within the healthcare system can aid in improving diagnoses as well as the control of diseases through monitoring. These devices can include glucose monitors that only require a ...

Point-of-care testing for group A beta-hemolytic Streptococcus (Strep A) significantly reduced antibiotic prescriptions in children and adults with signs of pharyngitis, even when used as the sole ...

Please provide your email address to receive an email when new articles are posted on . The FDA granted marketing authorization for Cepheid’s Xpert HCV test and GeneXpert Xpress System, the first ...

BOSTON & LONDON--(BUSINESS WIRE)--CA Healthcare Acquisition Corp (Nasdaq: CAHC), a special purpose acquisition company focused on investing in a growth-oriented healthcare company which recently ...